搜索筛选:
搜索耗时3.8719秒,为你在为你在102,285,761篇论文里面共找到 7 篇相符的论文内容
类      型:
[期刊论文] 作者:Yang Shen,Zhixiang Shen,Bin Ji, 来源:临床肿瘤与癌症研究:英文版 年份:2009
OBJECTIVE Though doxorubicin is highly activein the treatment of multiple myeloma, its toxicityprofile limits its therapeutic index. We performed thisstudy...
[期刊论文] 作者:Yang Shen,Zhixiang Shen,Bin Ji, 来源:临床肿瘤与癌症研究(英文版) 年份:2004
OBJECTIVE Though doxorubicin is highly active in the treatment of multiple myeloma, its toxicity profile limits its therapeutic index. We performed this study t...
[期刊论文] 作者:Yang Shen,Zhixiang Shen,Bin Ji, 来源:临床肿瘤与癌症研究(英文版) 年份:2009
OBJECTIVE Though doxorubicin is highly active in the treatment of multiple myeloma, its toxicity profile limits its therapeutic index. We performed this study t...
[期刊论文] 作者:Jun Zhu,Jun Ma,Union for China Lymphoma Investigators of Chinese Society of Clinical Oncology,Zhixiang Shen, 来源:中国癌症研究:英文版 年份:2021
1. General guidelines2. Diagnosis3. Staging4. Treatment4.1 Diffuse large B-cell lymphoma(DLBCL)4.2 Follicular lymphoma(FL)4.3 Mantle cell lymphoma(MCL)4.4 Marginal zone lymphoma(MZL)4.5 Burkitt lymphoma(BL)4.6 CLL/Small lymphocytic lymphoma......
[期刊论文] 作者:Xiaojun Huang,Qian Jiang,Jianda Hu,Jianyong Li,Jie Jin,Fanyi Meng,Zhixiang Shen,Ting Liu,Depei Wu,Jianmin, 来源:医学前沿 年份:2019
Dasatinib is a highly effective second-generation tyrosine kinase inhibitor used to treat chronic myeloid leukemia (CML).In 2007,a pivotal phase-2 study of dasa...
[会议论文] 作者:孙于谦,Fanyi Meng,Mingzhe Han,Xi Zhang,Li Yu,Heng Huang,Depei Wu,Hanyun Ren,Chun Wang,Zhixiang Shen,Yu Ji, 来源:中华医学会第一次全国血液病感染学术会议 年份:2015
The China Assessment of Antifungal Therapy in Hematological Disease (CAESAR) study, the first large-scale observational study of invasive fungal disease (IFD) i...
[会议论文] 作者:孙于谦,Xiaojun Huang,Fanyi Meng,Mingzhe Han,Xi Zhang,Li Yu,Heng Huang,Depei Wu,Hanyun Ren,Chun Wang,Zhixiang Shen, 来源:中华医学会第一次全国血液病感染学术会议 年份:2015
相关搜索: